| CRISPR Medicine | This is an overview of articles on safety
An new end-to-end nomination workflow improves the nomination of genomic sites that may be unintentionally edited by CRISPR-Cas, combining high...
Some of the best links we picked up around the internet
A new sensitive method detects large-scale chromosomal rearrangements caused by CRISPR-Cas9 genome editing in primary human cells. The approach...
Researchers in Denmark report today in Nature Communications about novel deep learning models that significantly improve the accuracy of predicting...
The small molecule AZD7648 has shown striking potential to enhance HDR in CRISPR editing, raising hopes for clinical translation. But a closer look by...
Irish-Indian company CyGenica is on a mission to solve the huge challenge surrounding targeted intracellular delivery of gene-editing and other...
Resistance to chemotherapy is a major challenge in the treatment of non-small cell lung cancer. By profiling the spectrum of outcomes arising from...
In 2022, we celebrate a decade of CRISPR as a game-changing tool in research and medicine. The last 10 years have been phenomenal, and CRISPR cures...
